Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Uterine Cervical Neoplasms 3Esophageal Neoplasms 3Lymphatic Metastasis 2Esophageal Squamous Cell Carcinoma 2Carcinoma, Non-Small-Cell Lung 2Recurrence 1Pathologic Complete Response 1Neoplasm Metastasis 1Melanoma 1Carcinoma, Squamous Cell 1Breast Neoplasms 1

Interventions

Cisplatin 10Paclitaxel 9Radiotherapy 5Fluorouracil 5Radiotherapy, Intensity-Modulated 4Docetaxel 4Carboplatin 4advexin 2Therapeutics 2Surveys and Questionnaires 2Oxaliplatin 2Leucovorin 2Drug Therapy 2Cetuximab 2Afatinib 2penpulimab 1pembrolizumab 1olaparib 1niraparib 1nimotuzumab 1nedaplatin 1durvalumab 1daromun 1camrelizumab 1calcipotriene 1atezolizumab 1afamelanotide 1TP protocol 1Surgical Procedures, Operative 1Radiotherapy, Adjuvant 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Carcinoma, Squamous Cell × TP protocol × Clear all
NCT02891083 2016-09-07

Adjuvant Therapies or Surgery Alone for High Risk pN0 Esophageal Cancer

Shanghai Chest Hospital

Phase 3 Unknown
486 enrolled
Gastrointestinal

Carcinoma, Squamous Cell, Esophageal Neoplasms, Lymphatic Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡